Business Description
Vitura Health Ltd
ISIN : AU0000266801
Share Class Description:
ASX:VIT: Ordinary SharesCompare
Compare
Traded in other countries / regions
VIT.Australia1CE0.Germany IPO Date
2019-11-07Description
Vitura Health Ltd is focused on creating medicinal cannabis products and digital health solutions that connect and strengthen the ecosystem between patients, prescribers, pharmacists, and suppliers. The company has three business segments namely, the Medical segment, which involves the sale of medicinal cannabis products; the Clinics segment, which involves the operation of medicinal cannabis clinics; and the Consumer segment, which involves the sale of consumer (non-medical) products in Australia and previously in Asia. The company generates the majority of its revenue from the Medical segment. Geographically the company generates the majority of its revenue from Australia.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.08 | |||||
| Equity-to-Asset | 0.54 | |||||
| Debt-to-Equity | 0.31 | |||||
| Debt-to-EBITDA | 0.8 | |||||
| Interest Coverage | 33.41 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 8.04 | |||||
| Beneish M-Score | -1.39 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 490.6 | |||||
| 3-Year Book Growth Rate | -15.4 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 25.66 | |||||
| 9-Day RSI | 29.57 | |||||
| 14-Day RSI | 33.49 | |||||
| 6-1 Month Momentum % | -46.38 | |||||
| 12-1 Month Momentum % | -37.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.39 | |||||
| Quick Ratio | 1.18 | |||||
| Cash Ratio | 0.57 | |||||
| Days Inventory | 31.91 | |||||
| Days Sales Outstanding | 32.79 | |||||
| Days Payable | 49.66 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 8.7 | |||||
| Dividend Payout Ratio | 0.59 | |||||
| Forward Dividend Yield % | 8.7 | |||||
| 5-Year Yield-on-Cost % | 9.52 | |||||
| 3-Year Average Share Buyback Ratio | -62.9 | |||||
| Shareholder Yield % | 5.88 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 31.22 | |||||
| Operating Margin % | 11.5 | |||||
| Net Margin % | 7.86 | |||||
| FCF Margin % | 9 | |||||
| ROE % | 27.44 | |||||
| ROA % | 16.81 | |||||
| ROIC % | 31.83 | |||||
| ROC (Joel Greenblatt) % | 160.66 | |||||
| ROCE % | 35.24 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 6.18 | |||||
| PE Ratio without NRI | 6.18 | |||||
| Price-to-Owner-Earnings | 4.2 | |||||
| PS Ratio | 0.5 | |||||
| PB Ratio | 1.54 | |||||
| Price-to-Tangible-Book | 11.5 | |||||
| Price-to-Free-Cash-Flow | 5.53 | |||||
| Price-to-Operating-Cash-Flow | 5.25 | |||||
| EV-to-EBIT | 4.69 | |||||
| EV-to-EBITDA | 4.35 | |||||
| EV-to-Revenue | 0.55 | |||||
| EV-to-FCF | 5.53 | |||||
| Price-to-Graham-Number | 1.64 | |||||
| Price-to-Net-Current-Asset-Value | 2.88 | |||||
| Earnings Yield (Greenblatt) % | 21.3 | |||||
| FCF Yield % | 16.25 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vitura Health Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 119.661 | ||
| EPS (TTM) (A$) | 0.017 | ||
| Beta | -1.42 | ||
| Volatility % | 84.89 | ||
| 14-Day RSI | 33.49 | ||
| 14-Day ATR (A$) | 0.018068 | ||
| 20-Day SMA (A$) | 0.161875 | ||
| 12-1 Month Momentum % | -37.29 | ||
| 52-Week Range (A$) | 0.092 - 0.6 | ||
| Shares Outstanding (Mil) | 575.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vitura Health Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vitura Health Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vitura Health Ltd Frequently Asked Questions
What is Vitura Health Ltd(ASX:VIT)'s stock price today?
The current price of ASX:VIT is A$0.12. The 52 week high of ASX:VIT is A$0.60 and 52 week low is A$0.09.
When is next earnings date of Vitura Health Ltd(ASX:VIT)?
The next earnings date of Vitura Health Ltd(ASX:VIT) is .
Does Vitura Health Ltd(ASX:VIT) pay dividends? If so, how much?
The Dividend Yield %  of Vitura Health Ltd(ASX:VIT) is 8.7% (As of Today), Highest Dividend Payout Ratio of Vitura Health Ltd(ASX:VIT) was 0.59. The lowest was 0.42. And the median was 0.42. The  Forward Dividend Yield % of Vitura Health Ltd(ASX:VIT) is 8.7%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers